Clinical Trials

566 enrolled

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

NCT04525989 2025-08-20

PRORECT

254 enrolled

Rectal Neoplasms

NCT07112781 2025-08-13

FAST-ONE

30 enrolled

Prostatic Neoplasms

NCT03649048 2025-07-31

RADIO

Head & Neck

Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT04545957 2025-07-28

JUMP

GastrointestinalGenitourinaryHead & Neck

86 enrolled

Adenocarcinoma, Head and Neck Neoplasms, Liver Neoplasms, Prostatic Neoplasms

NCT03858205 2025-07-11

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

Plasma cell

Multiple Myeloma

NCT06384053 2025-06-15

SAHARA

Dermatologic

Hyperthermia, Carcinoma, Basal Cell

NCT06501053 2025-06-06

CORRECT

110 enrolled

Rectal Neoplasms

NCT06995664 2025-05-29

VIRTUAL

24 enrolled

Carcinoma, Renal Cell

NCT06938360 2025-04-22

Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial

158 enrolled

Breast

Breast Neoplasms

NCT05857631 2025-04-15

PARCERII

90 enrolled

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT04745390 2025-03-11

SAVIOR

110 enrolled

Carcinoma, Hepatocellular

NCT06831981 2025-02-18

ARO 2024-13

264 enrolled

Hyperthermia, Rectal Neoplasms

NCT05190172 2025-02-12

PRO-GLIO

225 enrolled

CNS

Astrocytoma, Oligodendroglioma

NCT05142982 2025-02-11

Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma

74 enrolled

Seminoma

NCT05513443 2025-01-20

PRIS

184 enrolled

Prostatic Neoplasms

NCT06752044 2024-12-30

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

10 enrolled

Thoracic

Advanced NSCLC

NCT06752057 2024-12-30

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

10 enrolled

Thoracic

Advanced NSCLC

NCT06330545 2024-11-22

Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release

95 enrolled

Dupuytren Contracture

NCT06688760 2024-11-14

Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma

86 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06652022 2024-10-22

Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs

102 enrolled

Ureteral Neoplasms

NCT06613113 2024-09-25

Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.

30 enrolled

MSS Metastatic Colorectal Cancer

NCT04097067 2024-08-27

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

83 enrolled

Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT05397262 2024-05-09

HyBla_RCT

1,000 enrolled

Hyperthermia, Urinary Bladder Neoplasms

NCT06401447 2024-05-06

TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma

50 enrolled

Esophageal Squamous Cell Carcinoma

NCT06390176 2024-04-30

Lactobacillus Rhamnosus GG Alleviates Oral Mucositis in Patients Undergoing Radiotherapy

132 enrolled

Stomatitis

NCT06335693 2024-03-28

Adjuvant Hypofractionated Radiotherapy for Prostate Cancer

9 enrolled

Prostatic Neoplasms

NCT06330909 2024-03-26

HypoF-SBRT

374 enrolled

Prostatic Neoplasms

NCT06223295 2024-02-20

ENFORCE

356 enrolled

Prostatic Neoplasms

NCT04351204 2024-02-01

UMBRELLA-II

140 enrolled

Tumors at All Sites Which Will Receive Radiotherapy

NCT05760391 2023-07-25

A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.